Five major original publications
Orliaguet L., Ejlalmanesh T., Humbert A., Ballaire R., Diedisheim M., Julla J-B., Chokr D., Cuenco J., Michieletto J., Charbit J., Lindén D., Boucher J., Potier C., Hamimi A., Lemoine S., Blugeon C., Legoix P., Lameiras S., Baudrin L.G., Baulande S., Soprani A., Castelli F.A., Fenaille F., Riveline J-P., Dalmas E., Rieusset J., Gautier J-F., Venteclef N., Alzaid F. (2022). Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling. Nat Commun. Aug 30;13(1):5089. doi: 10.1038/s41467-022-32813-z.
Potier L., Mohammedi K., Saulnier P-J., Fumeron F., Halimi J-M., Venteclef N., Marre M., Hadjadj S., Roussel R., Velho G. (2022). Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes. Diabetes Care. Jul 7;45(7):1631-1639. doi: 10.2337/dc21-2638.
Julla J-B., Jacquemier P., Fagherazzi G., Vidal-Trecan T., Juddoo V., Jaziri A., Mersel H., Venteclef N., Roussel R., Massin P., Couturier A., Gautier J-F., Riveline J-P. (2021). Is the Consensual Threshold for Defining High Glucose Variability Implementable in Clinical Practice? Diabetes Care. Jul;44(7):1722-1725. doi: 10.2337/dc20-1847. Epub 2021 Jun 7.
Alzaid F., Julla J-B., Diedisheim M., Potier C., Potier L., Velho G., Gaborit B., Manivet P., Germain S., Vidal-Trecan T., Roussel R., Riveline J-P., Dalmas E., Venteclef N., Gautier J-F. (2020). Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes. EMBO Mol Med. Oct 7;12(10):e13038. doi: 10.15252/emmm.202013038. Epub 2020 Sep 11
Drareni K., Ballaire R., Alzaid F., Goncalves A., Chollet C., Barilla S., Nguewa J-L., Dias K., Lemoine S., Riveline J-P., Roussel R., Dalmas E., Velho G., Treuter E., Gautier J-F., Venteclef N. (2020). Adipocyte Reprogramming by the Transcriptional Coregulator GPS2 Impacts Beta Cell Insulin Secretion. Cell Rep. Sep 15;32(11):108141. doi: 10.1016/j.celrep.2020.108141.